VTVT insider filings

vTv Therapeutics Inc. — 50 most recent insider filings (SEC Forms 3/4/5) from EDGAR, normalized by FilingPulse. Latest filing: 2026-06-29. Screen VTVT transaction legs live →

Insider transaction summary — last 90 days

No insider filings (Forms 3/4/5) for VTVT between 2026-08-23 and 2026-11-21. The table below lists the most recent filings on record.

Recent insider filings — vTv Therapeutics Inc.

FiledFormInsiderReported transactionsSource
2026-06-294Al-Marzooqi Fahed — DirectorGrant/award (A): 6,000 (derivative) @ $35.08EDGAR
2026-06-294Phillips Anne M. — DirectorGrant/award (A): 6,000 (derivative) @ $35.08EDGAR
2026-06-294AKKARAJU SRINIVAS — DirectorGrant/award (A): 6,000 (derivative) @ $35.08EDGAR
2026-06-294SPIEGELMAN DANIEL K — DirectorGrant/award (A): 6,000 (derivative) @ $35.08EDGAR
2026-06-294BAKER BROS. ADVISORS LP — Director
667, L.P. — Director
Baker Brothers Life Sciences LP — Director
BAKER FELIX — Director
BAKER JULIAN — Director
Baker Bros. Advisors (GP) LLC — Director
Grant/award (A): 6,000 (derivative) @ $0 · Grant/award (A): 6,000 (derivative) @ $0EDGAR
2026-02-184Tung Michael Stephen — EVP & CFOGrant/award (A): 44,969 (derivative) @ $36.92EDGAR
2026-02-184SEKHRI PAUL J — Pres, CEO and Exec Chairperson, DirectorGrant/award (A): 140,000 (derivative) @ $36.92EDGAR
2025-09-254AKKARAJU SRINIVAS — DirectorGrant/award (A): 106,000 @ $15.27 · Grant/award (A): 877,214 (derivative) · Grant/award (A): 983,214 (derivative)EDGAR
2025-09-054AKKARAJU SRINIVAS — DirectorGrant/award (A): 655,523 (derivative) · Grant/award (A): 655,523 (derivative)EDGAR
2025-09-054BAKER BROS. ADVISORS LP — Director
667, L.P. — Director
Baker Brothers Life Sciences LP — Director
BAKER FELIX — Director
BAKER JULIAN — Director
Baker Bros. Advisors (GP) LLC — Director
Grant/award (A): 4,308 · Grant/award (A): 46,692 · Grant/award (A): 217,144 (derivative) · Grant/award (A): 2,353,913 (derivative) · Grant/award (A): 221,452 (derivative) · Grant/award (A): 2,400,605 (derivative)EDGAR
2025-06-124Al-Marzooqi Fahed — DirectorGrant/award (A): 4,000 (derivative) @ $16.59EDGAR
2025-06-124Phillips Anne M. — DirectorGrant/award (A): 4,000 (derivative) @ $16.59EDGAR
2025-06-124AKKARAJU SRINIVAS — DirectorGrant/award (A): 4,000 (derivative) @ $16.59EDGAR
2025-06-124SPIEGELMAN DANIEL K — DirectorGrant/award (A): 4,000 (derivative) @ $16.59EDGAR
2025-06-124BAKER BROS. ADVISORS LP — Director
667, L.P. — Director
Baker Brothers Life Sciences LP — Director
BAKER FELIX — Director
BAKER JULIAN — Director
Baker Bros. Advisors (GP) LLC — Director
Grant/award (A): 4,000 (derivative) @ $0 · Grant/award (A): 4,000 (derivative) @ $0EDGAR
2025-05-214Tung Michael Stephen — EVP & CFOGrant/award (A): 45,000 (derivative) @ $21.25EDGAR
2025-04-244AKKARAJU SRINIVAS — DirectorGrant/award (A): 2,250 (derivative) @ $17.22 · Grant/award (A): 983 (derivative) @ $17.22EDGAR
2025-03-074SEKHRI PAUL J — Pres, CEO and Exec Chairperson, DirectorGrant/award (A): 108,000 (derivative) @ $19.66EDGAR
2024-12-064Samsara BioCapital GP, LLC — 10% owner
Samsara BioCapital, L.P. — 10% owner
Other (J): 58,836 · Grant/award (A): 58,885 (derivative)EDGAR
2024-12-064AKKARAJU SRINIVAS — Director, 10% ownerDisposition to issuer (D): 58,836 · Grant/award (A): 58,885 (derivative)EDGAR
2024-11-194SEKHRI PAUL J — Pres, CEO and Exec Chairperson, DirectorPurchase (P): 1,378 @ $16.35 · Purchase (P): 1,778 @ $16.88 · Purchase (P): 1,844 @ $16.96EDGAR
2024-06-274Al-Marzooqi Fahed — DirectorGrant/award (A): 3,000 (derivative) @ $17.22EDGAR
2024-06-274Phillips Anne M. — DirectorGrant/award (A): 2,250 (derivative) @ $17.22 · Grant/award (A): 860 (derivative) @ $17.22EDGAR
2024-06-274SPIEGELMAN DANIEL K — DirectorGrant/award (A): 6,000 (derivative) @ $17.22EDGAR
2024-06-274BAKER BROS. ADVISORS LP — Director
667, L.P. — Director
Baker Brothers Life Sciences LP — Director
BAKER FELIX — Director
BAKER JULIAN — Director
Baker Bros. Advisors (GP) LLC — Director
Grant/award (A): 6,000 (derivative) @ $0 · Grant/award (A): 6,000 (derivative) @ $0 · Grant/award (A): 983 (derivative) @ $0 · Grant/award (A): 983 (derivative) @ $0EDGAR
2024-06-134Al-Marzooqi Fahed — DirectorGrant/award (A): 4,055 (derivative) @ $11.81EDGAR
2024-06-134Tuch Steven L. — Chief Financial OfficerGrant/award (A): 62,159 (derivative) @ $11.81EDGAR
2024-06-134Phillips Anne M. — DirectorGrant/award (A): 3,750 (derivative) @ $16.04EDGAR
2024-06-134SEKHRI PAUL J — President and CEO, DirectorGrant/award (A): 89,212 (derivative) @ $11.81EDGAR
2024-06-134AKKARAJU SRINIVAS — Director, 10% ownerGrant/award (A): 3,750 (derivative) @ $0EDGAR
2024-03-074BAKER BROS. ADVISORS LP — Director
667, L.P. — Director
Baker Brothers Life Sciences LP — Director
BAKER FELIX — Director
BAKER JULIAN — Director
Baker Bros. Advisors (GP) LLC — Director
Disposition to issuer (D): 4,776 @ $0 · Disposition to issuer (D): 52,881 @ $0 · Grant/award (A): 4,780 (derivative) @ $0 · Grant/award (A): 52,925 (derivative) @ $0EDGAR
2024-02-294AKKARAJU SRINIVAS — Director, 10% ownerGrant/award (A): 224,732 @ $11.81 · Grant/award (A): 833,693 (derivative) @ $11.80EDGAR
2023-06-214Al-Marzooqi Fahed — DirectorGrant/award (A): 75,000 (derivative) @ $0EDGAR
2023-06-214Harjivan Chandresh — DirectorGrant/award (A): 75,000 (derivative) @ $0EDGAR
2023-06-214Harris Keith R. — DirectorGrant/award (A): 75,000 (derivative) @ $0EDGAR
2023-06-214Weiner Howard L. — DirectorGrant/award (A): 75,000 (derivative) @ $0EDGAR
2023-06-214/AIsaacsohn Jonathan — DirectorHoldings only — no transactions reportedEDGAR
2023-06-214FRY JOHN A — DirectorGrant/award (A): 75,000 (derivative) @ $0EDGAR
2023-06-214KOZLOV HERSH — DirectorGrant/award (A): 75,000 (derivative) @ $0EDGAR
2022-12-134Tuch Steven L. — Chief Financial OfficerGrant/award (A): 500,000 (derivative) @ $0EDGAR
2022-11-304FRY JOHN A — DirectorPurchase (P): 20,539 @ $0.83 · Purchase (P): 40,461 @ $0.83EDGAR
2022-08-184Isaacsohn Jonathan — DirectorGrant/award (A): 50,000 (derivative) @ $0EDGAR
2022-08-174Harris Keith R. — DirectorGrant/award (A): 25,000 (derivative) @ $0EDGAR
2022-07-154Al-Marzooqi Fahed — DirectorGrant/award (A): 25,000 (derivative) @ $0EDGAR
2022-07-064Weiner Howard L. — DirectorGrant/award (A): 105,128 (derivative) @ $0EDGAR
2022-07-064Harjivan Chandresh — DirectorGrant/award (A): 25,000 (derivative) @ $0EDGAR
2022-07-064FRY JOHN A — DirectorGrant/award (A): 137,077 (derivative) @ $0EDGAR
2022-07-064KOZLOV HERSH — DirectorGrant/award (A): 105,128 (derivative) @ $0EDGAR
2022-03-044Nelson Rich S. — Acting Chief Executive Officer, DirectorGrant/award (A): 500,000 (derivative) @ $0EDGAR
2021-12-214PERELMAN RONALD O — 10% ownerSale (S): 87,000 @ $1.15EDGAR

Recent 8-K events — vTv Therapeutics Inc.

Items classified from EDGAR index headers. Browse recent 8-K filings market-wide, by item code →

FiledFormItems reportedSource
2026-11-058-K2.02 — Results of Operations and Financial Condition
9.01 — Financial Statements and Exhibits
EDGAR
2026-10-068-K5.03 — Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
9.01 — Financial Statements and Exhibits
EDGAR
2026-08-068-K2.02 — Results of Operations and Financial Condition
9.01 — Financial Statements and Exhibits
EDGAR
2026-06-298-K5.07 — Submission of Matters to a Vote of Security HoldersEDGAR
2026-05-138-K8.01 — Other Events
9.01 — Financial Statements and Exhibits
EDGAR
2026-05-138-K2.02 — Results of Operations and Financial Condition
9.01 — Financial Statements and Exhibits
EDGAR
2026-03-108-K2.02 — Results of Operations and Financial Condition
9.01 — Financial Statements and Exhibits
EDGAR
2026-03-108-K7.01 — Regulation FD Disclosure
9.01 — Financial Statements and Exhibits
EDGAR
2026-02-268-K7.01 — Regulation FD Disclosure
9.01 — Financial Statements and Exhibits
EDGAR
2026-02-028-K1.01 — Entry into a Material Definitive AgreementEDGAR
Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?ticker=VTVT returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. Get a free API key → · API docs